Frederick J. Fritz

CIK: 0001525250

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMNN

Imunon, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

IMNN
Imunon, Inc.
Jul 31, 2026
Award(A)
Direct
6.9K shares at avg. $1.59$11K
IMNN
Imunon, Inc.
May 22, 2026
Award(A)
Direct
10.3K shares at avg. $2.20$23K
IMNN
Imunon, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5.9K shares-
IMNN
Imunon, Inc.
Aug 4, 2025
Award(A)
Direct
3.2K shares at avg. $9.20$29K
IMNN
Imunon, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3.8K shares-
IMNN
Imunon, Inc.
Sep 6, 2024
Award(A)
Stock Option (Right to Buy)
Direct
6.7K shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	IMNN Imunon, Inc.	Award(A)	6,934	$1.59	$11,025	Direct
May 22, 2026	IMNN Imunon, Inc.	Award(A)	10,330	$2.20	$22,726	Direct
Jan 2, 2026	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	5,892	-	-	Direct
Aug 4, 2025	IMNN Imunon, Inc.	Award(A)	3,161	$9.20	$29,081	Direct
Mar 14, 2025	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	3,750	-	-	Direct
Sep 6, 2024	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	6,737	-	-	Direct

1-6 of 6 transactions

About Fritz Frederick J.

Fritz Frederick J. (SEC CIK 0001525250) files insider reports with the SEC as Director of Imunon, Inc. (IMNN).

Signal8 holds 6 ownership filings by Fritz Frederick J., all Form 4s, filed between Sep 10, 2024 and Aug 4, 2026. Those filings report 6 transactions, from Sep 6, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fritz Frederick J.'s filings is in LAWRENCEVILLE, NJ.

Recent filings by Fritz Frederick J.

Jul 31, 2026: Grant or award of IMNN shares (Form 4, code A).
May 22, 2026: Grant or award of IMNN shares (Form 4, code A).
Jan 2, 2026: Grant or award of IMNN derivative securities (Form 4, code A).
Aug 4, 2025: Grant or award of IMNN shares (Form 4, code A).
Mar 14, 2025: Grant or award of IMNN derivative securities (Form 4, code A).

Other insiders filing for Imunon, Inc. (IMNN)

Tardugno Michael H, Executive Chairman of Board
Lindborg Stacy, President and CEO
Faller Douglas Vincent, Chief Medical Officer
Eylward Susan, General Counsel and Corp Sec
Pellizzari Christine A, Director
Dentzer James E, Director

How to read Form 4 transaction codes